Pharyngitis Completed Phase 3 Trials for Ambroxol (DB06742)

Also known as: Swelling of the pharynx / Pharyngeal inflammation / Pharyngitis NOS / Pharyngitis (disorder)

IndicationStatusPhase
DBCOND0010494 (Pharyngitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03583658Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute PharyngitisTreatment
NCT00525044Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore ThroatTreatment
NCT00148499Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/ViralpharyngitisTreatment
NCT00144274Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral PharyngitisTreatment